{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"description":"Per RECIST criteria (v1.1) and assessed by magnetic resonance imaging (MRI): Complete response (CR), Disappearance of all target lesions.","groups":[{"description":"Rituximab: (i.v.) 375 mg/m\\^2 given the evening before blood brain barrier disruption(BBBD) procedure day 1 Carboplatin: (i.a.) 200 mg/m\\^2 /day x 2 days = 400 mg/m\\^2","id":"OG000","title":"Rituximab and Carboplatin"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"2 years","title":"Number of Participants With a Complete Response Rate to Chemotherapy Regimen Assessed by Radiographic Response at 2 Years.","type":"PRIMARY","unitOfMeasure":"Participants"}